Categories
All News

Cataract Surgery Devices Market Report- Future with Size, Share, Growth, and Key Companies Analysis- Advanced Refractive Technologies Inc

ReportsnReports added a new report on The Cataract Surgery Devices Market report delivers the clean elaborated structure of the Report comprising each and every business related information of the market at a global level. The complete range of information related to the Cataract Surgery Devices Market is obtained through various sources and this obtained bulk of the information is arranged, processed, and represented by a group of specialists through the application of different methodological techniques and analytical tools such as SWOT analysis to generate a whole set of trade based study regarding the Cataract Surgery Devices Market.

Download FREE PDF sample of this Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=2826319

Cataract Surgery Devices Market Top Companies and Product Overview:-
Advanced Refractive Technologies Inc
Altacor Ltd
Bausch & Lomb Inc
Cirle, Inc
Dutch Ophthalmic Research Center International BV
Eye Care and Cure
Hebrew University of Jerusalem

and more…

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cataract Surgery Devices pipeline products.

Table of Contents in this Report-
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Cataract Surgery Devices Overview 8
3 Products under Development 9
3.1 Cataract Surgery Devices – Pipeline Products by Stage of Development 9
3.2 Cataract Surgery Devices – Pipeline Products by Segment 10
3.3 Cataract Surgery Devices – Pipeline Products by Territory 11
3.4 Cataract Surgery Devices – Pipeline Products by Regulatory Path 12
3.5 Cataract Surgery Devices – Pipeline Products by Estimated Approval Date 13
3.6 Cataract Surgery Devices – Ongoing Clinical Trials 14
4 Cataract Surgery Devices – Pipeline Products under Development by Companies 15
4.1 Cataract Surgery Devices Companies – Pipeline Products by Stage of Development 15
4.2 Cataract Surgery Devices – Pipeline Products by Stage of Development 16
5 Cataract Surgery Devices Companies and Product Overview 17
5.1 Advanced Refractive Technologies Inc Company Overview 17
5.1.1 Advanced Refractive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 17
5.2 Altacor Ltd Company Overview 18
5.2.1 Altacor Ltd Pipeline Products & Ongoing Clinical Trials Overview 18
5.3 Bausch & Lomb Inc Company Overview 19
5.3.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 19
5.4 Cirle, Inc Company Overview 26
5.4.1 Cirle, Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.5 Dutch Ophthalmic Research Center International BV Company Overview 27
5.5.1 Dutch Ophthalmic Research Center International BV Pipeline Products & Ongoing Clinical Trials Overview 27
5.6 Eye Care and Cure Company Overview 28
5.6.1 Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview 28
5.7 Hebrew University of Jerusalem Company Overview 29
5.7.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 29
5.8 Iantech Inc Company Overview 30
5.8.1 Iantech Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.9 International BioMedical Devices Inc Company Overview 31
5.9.1 International BioMedical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 31
5.10 Medicontur Medical Engineering Ltd Company Overview 32
5.10.1 Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
5.11 Mynosys Cellular Devices, Inc. Company Overview 33
5.11.1 Mynosys Cellular Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
5.12 OptoLight Vision Technology Company Overview 35
5.12.1 OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview 35
5.13 Paradigm Medical Industries, Inc. (Inactive) Company Overview 38
5.13.1 Paradigm Medical Industries, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 38
5.14 Shanghai Haohai Biological Technology Co Ltd Company Overview 39
5.14.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
5.15 STAAR Surgical Company Company Overview 40
5.15.1 STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview 40
5.16 Tear Diagno LLC (Inactive) Company Overview 41
5.16.1 Tear Diagno LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 41
5.17 University of California Los Angeles Company Overview 42
5.17.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 42
5.18 University of Florida Company Overview 43
5.18.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 43
5.19 University of Michigan Company Overview 44
5.19.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 44
5.20 University of Texas Medical Branch at Galveston Company Overview 45
5.20.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 45
5.21 VSY Biotechnology BV Company Overview 46
5.21.1 VSY Biotechnology BV Pipeline Products & Ongoing Clinical Trials Overview 46
5.22 Wake Forest Baptist Medical Center Company Overview 47
5.22.1 Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 47
6 Cataract Surgery Devices- Recent Developments 48
6.1 Nov 20, 2019: Baring Private Equity Asia signs agreement to buy Lumenis 48
6.2 Nov 19, 2019: Alcon reports third quarter and nine months 2019 results 48
6.3 Nov 12, 2019: Ocular Therapeutix reports third quarter 2019 financial results and business update 51
6.4 Nov 06, 2019: Glaukos Corporation announces third quarter 2019 financial results 53
6.5 Nov 04, 2019: Bausch Health Companies announces third-quarter 2019 results and raises full-year revenue and adjusted EBITDA (non-GAAP) guidance ranges 54
7.1 Methodology 123
and more
https://bisouv.com/